Cargando…

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

Alzheimer’s disease (AD) is a large and increasing unmet medical need with no disease-modifying treatment currently available. Genetic evidence from genome-wide association studies (GWASs) and gene network analysis has clearly revealed a key role of the innate immune system in the brain, of which mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biber, Knut, Bhattacharya, Anindya, Campbell, Brian M., Piro, Justin R., Rohe, Michael, Staal, Roland G.W., Talanian, Robert V., Möller, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716448/ https://www.ncbi.nlm.nih.gov/pubmed/31507408 http://dx.doi.org/10.3389/fphar.2019.00840

Ejemplares similares

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
por: Hinkson, Izumi V., et al.
Publicado: (2020)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010)

Early identification of hERG liability in drug discovery programs by automated patch clamp
por: Danker, Timm, et al.
Publicado: (2014)

Improving Pediatric Drug Development: Challenges, Opportunities and Lessons Learned
por: Mattison, Donald R.
Publicado: (2010)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Label-free drug discovery
por: Fang, Ye
Publicado: (2014)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Structures, Substrates, and Regulators of Mammalian Sirtuins – Opportunities and Challenges for Drug Development
por: Moniot, Sébastien, et al.
Publicado: (2012)

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
por: Swain, Shasank Sekhar, et al.
Publicado: (2023)

Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Drug Discovery of DKK1 Inhibitors
por: Jiang, Hewen, et al.
Publicado: (2022)

Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease
por: Anastasio, Thomas J.
Publicado: (2015)

KRIBB11: A Promising Drug that Promotes Microglial Process Elongation and Suppresses Neuroinflammation
por: Su, Jianbin, et al.
Publicado: (2022)

Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines
por: Han, Lu, et al.
Publicado: (2021)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)

From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
por: Bordon, Karla de Castro Figueiredo, et al.
Publicado: (2020)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

AI in drug discovery: Applications, opportunities, and challenges
por: Bittner, Martin-Immanuel, et al.
Publicado: (2022)

Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023)

Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data
por: Yildirim, Oktay, et al.
Publicado: (2016)

Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities
por: Yin, Qingqing, et al.
Publicado: (2023)

Bioluminescent Zebrafish Transplantation Model for Drug Discovery
por: Hason, Martina, et al.
Publicado: (2022)

Limits of Prediction for Machine Learning in Drug Discovery
por: von Korff, Modest, et al.
Publicado: (2022)

The brain’s best friend: microglial neurotoxicity revisited
por: Hellwig, Sabine, et al.
Publicado: (2013)

The Hungry Stomach: Physiology, Disease, and Drug Development Opportunities
por: Sanger, Gareth J., et al.
Publicado: (2011)

Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1
por: Smith, Nicola J.
Publicado: (2015)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

From Genome to Drugs: New Approaches in Antimicrobial Discovery
por: Serral, Federico, et al.
Publicado: (2021)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

MBC and ECBL libraries: outstanding tools for drug discovery
por: Ginex, Tiziana, et al.
Publicado: (2023)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

New directions for drug discovery
por: Spedding, Michael
Publicado: (2006)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae
por: Ohnesorge, Nils, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3lsvop27qtn1d31dii3t3l3gj